(UN)FOLLOW-UP OF HYPERTENSIVE PATIENTS IN A YEAR OF THE COVID-19 PANDEMIC – THE REALITY OF A FAMILY HEALTH UNIT
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.58043/rphrc.66 |
Resumo: | Introduction: Hypertension is a prevalent problem whose follow-up occurs mainly in Primary Health Care (PHC). The need to respond to the COVID-19 pandemic led to restructuring and changes in the provision of services, with a consequent decrease in scheduled activity. Objectives: To assess the impact of the COVID-19 pandemic on the follow-up and health status of hypertensive patients by evaluating 3 outcomes: (i) Percentage of patients who complied with existing recommendations for the follow-up of hypertensive patients under of the PHC; (ii) Percentage of patients who started and/or intensified antihypertensive drug therapy during this period; Comparison of the blood pressure profile of patients without pharmacological changes before and after the scheduled activity suspension date. Methods: Selection of patients from the Family Health Unit Marco with the code K86 or K87 (Hypertension with or without complications) on 02/01/2020; Exclusion criteria: users not followed at the Family Health Unit and without consultation within 6 months before the date of suspension of the scheduled activity. Variables: gender, age, blood pressure, heart rate, body mass index, usual medication and date of consultations held between 15/09/2019 and 01/02/2021; Analysis: t test - continuous variables before and after the scheduled activity suspension date; McNemar test - categorical variables. Significance level: p<0.05. Results: n=1740. Only 27.6% hypertensive patients complied with the follow-up recommendations. 10.2% of patients started and/ or intensified antihypertensive drug therapy. There was a significant worsening in the tension profile (SBP [128.2 vs 134.3mmHg, p<0.001], DBP (74.9 vs 77.6mmHg, p<0.001) and MBP [92.7 vs 96.5mmHg, p<0.001]) and a significant reduction in the percentage of controlled hypertensive patients (BP<140/90mmHg) in patients not subject to pharmacological changes before and after suspension of scheduled activity (95.9% vs 80.3%, p<0.001). Conclusions: The pandemic had a negative impact on the follow-up and health status of hypertensive patients followed in PHC. Accelerating the process of returning to the programmed face-to-face activity and monitoring these patients by other means (eg teleconsultation) will be essential to reverse this trend and improve their outcome. |
id |
RCAP_b06320de69bcf7f7efd9515e600f3a11 |
---|---|
oai_identifier_str |
oai:ojs.revistahipertensao.pt:article/66 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
(UN)FOLLOW-UP OF HYPERTENSIVE PATIENTS IN A YEAR OF THE COVID-19 PANDEMIC – THE REALITY OF A FAMILY HEALTH UNIT(DES)FOLLOW-UP DOS DOENTES HIPERTENSOS EM ANO DE PANDEMIA COVID-19 – A REALIDADE DE UMA UNIDADE DE SAÚDE FAMILIARHipertensãoCOVID-19SARS-CoV-2Cuidados de Saúde PrimáriosFollow-UpHypertensionCOVID-19SARS-CoV-2Primary CareFollow-UpIntroduction: Hypertension is a prevalent problem whose follow-up occurs mainly in Primary Health Care (PHC). The need to respond to the COVID-19 pandemic led to restructuring and changes in the provision of services, with a consequent decrease in scheduled activity. Objectives: To assess the impact of the COVID-19 pandemic on the follow-up and health status of hypertensive patients by evaluating 3 outcomes: (i) Percentage of patients who complied with existing recommendations for the follow-up of hypertensive patients under of the PHC; (ii) Percentage of patients who started and/or intensified antihypertensive drug therapy during this period; Comparison of the blood pressure profile of patients without pharmacological changes before and after the scheduled activity suspension date. Methods: Selection of patients from the Family Health Unit Marco with the code K86 or K87 (Hypertension with or without complications) on 02/01/2020; Exclusion criteria: users not followed at the Family Health Unit and without consultation within 6 months before the date of suspension of the scheduled activity. Variables: gender, age, blood pressure, heart rate, body mass index, usual medication and date of consultations held between 15/09/2019 and 01/02/2021; Analysis: t test - continuous variables before and after the scheduled activity suspension date; McNemar test - categorical variables. Significance level: p<0.05. Results: n=1740. Only 27.6% hypertensive patients complied with the follow-up recommendations. 10.2% of patients started and/ or intensified antihypertensive drug therapy. There was a significant worsening in the tension profile (SBP [128.2 vs 134.3mmHg, p<0.001], DBP (74.9 vs 77.6mmHg, p<0.001) and MBP [92.7 vs 96.5mmHg, p<0.001]) and a significant reduction in the percentage of controlled hypertensive patients (BP<140/90mmHg) in patients not subject to pharmacological changes before and after suspension of scheduled activity (95.9% vs 80.3%, p<0.001). Conclusions: The pandemic had a negative impact on the follow-up and health status of hypertensive patients followed in PHC. Accelerating the process of returning to the programmed face-to-face activity and monitoring these patients by other means (eg teleconsultation) will be essential to reverse this trend and improve their outcome.Introdução: A Hipertensão Arterial é um problema prevalente cujo seguimento decorre principalmente nos Cuidados de Saúde Primários (CSP). A necessidade de dar resposta à pandemia COVID-19 levou a reestruturações e alterações na prestaçãode serviços com consequente diminuição da atividade programada. Objetivos: Avaliar o impacto da pandemia COVID-19 no follow-up e status de saúde dos hipertensos através da avaliação de 3 outcomes: (i) Percentagem de doentes que cumpriram com as recomendações existentes para o follow-up de doentes hipertensos no âmbito dos CSP; (ii) Percentagem de doentes que iniciaram e/ou intensificaram terapêutica farmacológica anti-hipertensiva nesse período; Comparação do perfil tensional dos doentes sem alterações farmacológicas antes e após a data de suspensão da atividade programada. Métodos: Seleção dos doentes da Unidade Saúde Familiar (USF) Marco com a codificação K86 ou K87 (Hipertensão com ou sem complicações) a 01/02/2020; Critérios de exclusão: utentes não seguidos na USF e sem consulta nos 6 meses antes da data da suspensão da atividade programada. Variáveis: género, idade, pressão arterial, frequência cardíaca, índice de massa corporal, medicação habitual e data das consultas realizadas entre 15/09/2019 e 01/02/2021; Análise: teste t - variáveis contínuas antes e após a data de suspensão da atividade programada; Teste McNemar - variáveis categóricas. Nível de significância: p<0.05. Resultados: n=1740. Apenas 27.6% hipertensos cumpriram com as recomendações de seguimento. 10.2% dos doentes iniciaram e/ou intensificaram terapêutica farmacológica anti-hipertensiva. Verificou-se um agravamento significativono perfil tensional (PAS [128.2 vs 134.3mmHg, p<0.001], PAD (74.9 vs 77.6mmHg, p<0.001) e PAM [92.7 vs 96.5mmHg, p<0.001]) e uma redução significativa na percentagem de hipertensos controlados (PA<140/90mmHg) nos doentes não sujeitos a alteraçõesfarmacológicas antes e após a suspensão da atividade programada (95.9% vs 80.3%,p<0.001). Conclusões: A pandemia teve um impacto negativo no follow-up e status de saúde dos hipertensos seguidos nos CSP. A aceleração do processo de retorno à atividade presencial programada e o acompanhamento destes doentes por outros meios (p. ex. teleconsulta), serão fulcrais para inverter esta tendência e melhorar o seu outcome.Revista Portuguesa de Hipertensão e Risco Cardiovascular2023-02-13info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.58043/rphrc.66https://doi.org/10.58043/rphrc.66Revista Portuguesa de Hipertensão e Risco Cardiovascular; N.º 91 (2022): Setembro/Outubro; 8-141646-8287reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revistahipertensao.pt/index.php/rh/article/view/66https://revistahipertensao.pt/index.php/rh/article/view/66/66Direitos de Autor (c) 2023 Filipe Cabralinfo:eu-repo/semantics/openAccessCabral, Filipe2024-02-03T07:36:50Zoai:ojs.revistahipertensao.pt:article/66Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:46:56.848667Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
(UN)FOLLOW-UP OF HYPERTENSIVE PATIENTS IN A YEAR OF THE COVID-19 PANDEMIC – THE REALITY OF A FAMILY HEALTH UNIT (DES)FOLLOW-UP DOS DOENTES HIPERTENSOS EM ANO DE PANDEMIA COVID-19 – A REALIDADE DE UMA UNIDADE DE SAÚDE FAMILIAR |
title |
(UN)FOLLOW-UP OF HYPERTENSIVE PATIENTS IN A YEAR OF THE COVID-19 PANDEMIC – THE REALITY OF A FAMILY HEALTH UNIT |
spellingShingle |
(UN)FOLLOW-UP OF HYPERTENSIVE PATIENTS IN A YEAR OF THE COVID-19 PANDEMIC – THE REALITY OF A FAMILY HEALTH UNIT Cabral, Filipe Hipertensão COVID-19 SARS-CoV-2 Cuidados de Saúde Primários Follow-Up Hypertension COVID-19 SARS-CoV-2 Primary Care Follow-Up |
title_short |
(UN)FOLLOW-UP OF HYPERTENSIVE PATIENTS IN A YEAR OF THE COVID-19 PANDEMIC – THE REALITY OF A FAMILY HEALTH UNIT |
title_full |
(UN)FOLLOW-UP OF HYPERTENSIVE PATIENTS IN A YEAR OF THE COVID-19 PANDEMIC – THE REALITY OF A FAMILY HEALTH UNIT |
title_fullStr |
(UN)FOLLOW-UP OF HYPERTENSIVE PATIENTS IN A YEAR OF THE COVID-19 PANDEMIC – THE REALITY OF A FAMILY HEALTH UNIT |
title_full_unstemmed |
(UN)FOLLOW-UP OF HYPERTENSIVE PATIENTS IN A YEAR OF THE COVID-19 PANDEMIC – THE REALITY OF A FAMILY HEALTH UNIT |
title_sort |
(UN)FOLLOW-UP OF HYPERTENSIVE PATIENTS IN A YEAR OF THE COVID-19 PANDEMIC – THE REALITY OF A FAMILY HEALTH UNIT |
author |
Cabral, Filipe |
author_facet |
Cabral, Filipe |
author_role |
author |
dc.contributor.author.fl_str_mv |
Cabral, Filipe |
dc.subject.por.fl_str_mv |
Hipertensão COVID-19 SARS-CoV-2 Cuidados de Saúde Primários Follow-Up Hypertension COVID-19 SARS-CoV-2 Primary Care Follow-Up |
topic |
Hipertensão COVID-19 SARS-CoV-2 Cuidados de Saúde Primários Follow-Up Hypertension COVID-19 SARS-CoV-2 Primary Care Follow-Up |
description |
Introduction: Hypertension is a prevalent problem whose follow-up occurs mainly in Primary Health Care (PHC). The need to respond to the COVID-19 pandemic led to restructuring and changes in the provision of services, with a consequent decrease in scheduled activity. Objectives: To assess the impact of the COVID-19 pandemic on the follow-up and health status of hypertensive patients by evaluating 3 outcomes: (i) Percentage of patients who complied with existing recommendations for the follow-up of hypertensive patients under of the PHC; (ii) Percentage of patients who started and/or intensified antihypertensive drug therapy during this period; Comparison of the blood pressure profile of patients without pharmacological changes before and after the scheduled activity suspension date. Methods: Selection of patients from the Family Health Unit Marco with the code K86 or K87 (Hypertension with or without complications) on 02/01/2020; Exclusion criteria: users not followed at the Family Health Unit and without consultation within 6 months before the date of suspension of the scheduled activity. Variables: gender, age, blood pressure, heart rate, body mass index, usual medication and date of consultations held between 15/09/2019 and 01/02/2021; Analysis: t test - continuous variables before and after the scheduled activity suspension date; McNemar test - categorical variables. Significance level: p<0.05. Results: n=1740. Only 27.6% hypertensive patients complied with the follow-up recommendations. 10.2% of patients started and/ or intensified antihypertensive drug therapy. There was a significant worsening in the tension profile (SBP [128.2 vs 134.3mmHg, p<0.001], DBP (74.9 vs 77.6mmHg, p<0.001) and MBP [92.7 vs 96.5mmHg, p<0.001]) and a significant reduction in the percentage of controlled hypertensive patients (BP<140/90mmHg) in patients not subject to pharmacological changes before and after suspension of scheduled activity (95.9% vs 80.3%, p<0.001). Conclusions: The pandemic had a negative impact on the follow-up and health status of hypertensive patients followed in PHC. Accelerating the process of returning to the programmed face-to-face activity and monitoring these patients by other means (eg teleconsultation) will be essential to reverse this trend and improve their outcome. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-02-13 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.58043/rphrc.66 https://doi.org/10.58043/rphrc.66 |
url |
https://doi.org/10.58043/rphrc.66 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revistahipertensao.pt/index.php/rh/article/view/66 https://revistahipertensao.pt/index.php/rh/article/view/66/66 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2023 Filipe Cabral info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2023 Filipe Cabral |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Revista Portuguesa de Hipertensão e Risco Cardiovascular |
publisher.none.fl_str_mv |
Revista Portuguesa de Hipertensão e Risco Cardiovascular |
dc.source.none.fl_str_mv |
Revista Portuguesa de Hipertensão e Risco Cardiovascular; N.º 91 (2022): Setembro/Outubro; 8-14 1646-8287 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130940927115264 |